OvaScience Securities Litigation
HomeCase DocumentsContact UsFile A Claim

Welcome to the OvaScience Securities Litigation Website

This website has been established to provide general information related to the proposed settlement of the case known as Dahhan v. OvaScience, Inc., et al., Civil Action No. 1:17-cv-10511-IT (the "Action"), pending before the United States District Court for the District of Massachusetts (the "Court"). The capitalized terms used on this website, and not otherwise defined, shall have the same meanings ascribed to them in the Stipulation and Agreement of Settlement dated March 4, 2022 (the "Stipulation"), which can be found and downloaded by clicking on the Case Documents tab above. Your rights may be affected by the Settlement if you purchased or otherwise acquired OvaScience, Inc. ("OvaScience" or the "Company") common stock between December 17, 2014 and September 28, 2015, inclusive (the “Class Period”).

The entity that leads the Litigation, Reedman Family Investments LLC, is referred to as the “Class Representative” or “Lead Plaintiff.” The entities and individuals, OvaScience, Longwood Fund, L.P., Longwood Fund, GP, LLC (“Longwood Funds”), and Michelle Dipp (“Dipp”), Jeffrey E. Young (“Young”), and Richard Aldrich (“Aldrich”) (“Individual Defendants”). OvaScience, Dipp, and Young are collectively referred to as the “OvaScience Defendants.” The Longwood Funds and Aldrich are the “Longwood Defendants.” Collectively, the Individual Defendants, the OvaScience Defendants, and the Longwood Defendants, being sued are the “Defendants.”

The law firm of Robbins Geller Rudman & Dowd LLP (“Lead Counsel”) represent Class Members. Class Members will not be charged for these lawyers. They will be paid from the Settlement Fund to the extent the Court approves their application for fees and expenses.


As more fully described in the Notice of (I) Proposed Settlement and Plan of Allocation; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses(the "Settlement Notice"), on August 25, 2017, Lead Plaintiff filed an amended complaint in the Action, the Amended Class Action Complaint (the “Complaint”). The Complaint asserts claims against OvaScience and Dipp under Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, and against Dipp and Young under Section 20(a) of the Exchange Act. Among other things, the Complaint alleges that, during the Class Period, the OvaScience Defendants knowingly or recklessly misrepresented and concealed material facts regarding the efficacy and commercial viability of AUGMENT. More specifically, the Complaint alleges that throughout the Class Period, the OvaScience Defendants made numerous public statements that led investors to believe that AUGMENT worked, and that there was significant demand from patients, which caused OvaScience’s common stock to allegedly trade at artificially inflated prices during the Class Period. The Complaint further alleges that the price of OvaScience stock declined when the true facts concerning the OvaScience Defendants’ alleged misrepresentations and omissions were revealed, resulting in financial losses to those who purchased or acquired OvaScience common stock during the Class Period at the inflated prices.


Pursuant to the Settlement, Defendants have agreed to pay or caused to be paid a total of $15,000,000 in cash (the “Settlement Amount”). The Settlement Amount will be deposited into an escrow account. The Settlement Amount plus any interest earned thereon is referred to as the “Settlement Fund.” If the Settlement is approved by the Court and the Effective Date occurs, the Net Settlement Fund will be distributed to Class Members who submit valid Claim Forms, in accordance with the proposed Plan of Allocation or such other plan of allocation as the Court may approve.


Although the information in this website is intended to assist you, it does not replace the information contained in the Settlement Notice and Stipulation, both of which can be found and downloaded by clicking on the Case Documents tab above. We recommend that you read the Notice and other relevant case documents carefully.


SUBMIT A CLAIM FORM This is the only way to be eligible to receive a payment from the Settlement Fund. If you are a Class Member, you will be bound by the Settlement as approved by the Court and you will give up any Released Plaintiff’s Claims that you have against Defendants and the other Defendants’ Releasees, so it is in your interest to submit a Claim Form.
EXCLUDE YOURSELF If you exclude yourself from the Class, you will not be eligible to receive any payment from the Settlement Fund. This is the only option that allows you to ever be part of any other lawsuit against the Defendants or any Defendants Releasees concerning the Released Plaintiff’s Claims.

Exclusions must be postmarked on or before July 5, 2022. If you excluded yourself from the Class in connection with the Notice of Pendency of Class Action provided in or around July 2020, you do not have to do so again.

OBJECT TO THE SETTLEMENT If you do not like the proposed Settlement, the proposed Plan of Allocation, or the request for attorneys’ fees and Litigation Expenses, you may write to the Court and explain why you do not like them. You cannot object to the Settlement, the Plan of Allocation, or the fee and expense request unless you are a Class Member.

Object to the settlement by submitting a written objection so that it is received no later than July 5, 2022.

GO TO THE HEARING ON JULY 26, 2022, AT 2:45 P.M. Filing a written objection and notice of intention to appear by July 5, 2022 allows you to speak in Court, at the discretion of the Court, about the fairness of the proposed Settlement, the Plan of Allocation, and/or the request for attorneys’ fees and Litigation Expenses. In the Court’s discretion, the July 26, 2022 hearing may be conducted by telephone or video conference. If you submit a written objection, you may (but you do not have to) participate in the hearing and, at the discretion of the Court, speak to the Court about your objection.
DO NOTHING If you are a member of the Class and you do not submit a valid Claim Form, you will not be eligible to receive any payment from the Settlement Fund. You will, however, remain a member of the Class, which means that you will be bound by any judgments or orders entered by the Court in the Action.


Submit Claim Form: August 22, 2022
File Objection: July 5, 2022
Request Exclusion: July 5, 2022
File Notice of Intention to Appear: July 5, 2022
Court Hearing on Fairness of Settlement: July 26, 2022, at 2:45 p.m.